Авторы

  • Mirsharapov U.
  • Gafurov B.

Ключевые слова:

prostate gland, chronic prostatitis, morphology, stroma, chronic inflammation, intraprostatic reflux, immune inflammation, cellular apoptosis, prostaglandins, cytokines, inflammatory infiltration.

Библиографические ссылки

1. Alyaev, Yu.G., Grigoryan, V.A., & Chalyi, M.E. Disorders of Sexual and Reproductive Function in Men. Moscow: Litterra; 2006. 188 p.

2. Karimov, Sh.I., Khadjibaev, A.M., & Khashimov, B.B. Urology. Tashkent: Tib Publishing House; 2010. 456 p.

3. Lopatkin, N.A. (Ed.). Urology: National Guidelines. Moscow: GEOTAR-Media; 2011. 1024 p.

4. Pushkar, D.Yu., & Rasner, P.I. Chronic Prostatitis: Diagnosis and Treatment. Moscow: MEDpress-inform; 2016. 96 p.

5. Tiktinsky, O.L., & Kalinina, S.N. Prostatitis. St. Petersburg: Media Press; 1994. 320 p.

6. Agarwal A, Virk G, Ong C, du Plessis SS. Effect of oxidative stress on male reproduction. World Journal of Men's Health. 2014;32(1):1–17.

7. Anderson RU, Wise D, Sawyer T. Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome. Journal of Urology. 2015;174(5): 1748–1751.

8. Bhatt DL, Bhatt DL. Inflammation and prostate gland dysfunction: Current insights. European Urology. 2017;72(4):534–543.

9. Bhowmick NA, Chytil A, Bhowmick NA. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science. 2004; 303:848–851.

10. Catalona WJ, Partin AW, Slawin KM. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease. JAMA. 2003;279(19):1542–1547.

11. Cornel EB, Kiemeney LA, Witjes JA. The relationship between lower urinary tract symptoms and prostate cancer. World Journal of Urology. 2014;25(6):597–603.

12. De Marzo AM, Meeker AK, Zha S, et al. Human prostate cancer precursors and pathobiology. Urology. 1999;62(5 Suppl 1):55–62.

13. Debes JD, Tindall DJ. The role of androgens and the androgen receptor in prostate cancer. Cancer Letters. 2002;187(1–2):1–7.

14. Drake RR, Jones EE, Powers TW, et al. Profiling of remaining glycans on formalin-fixed paraffin-embedded tissues using mass spectrometry imaging. Analytical Chemistry. 2018;90(14):8365–8372.

15. Ellem SJ, Risbridger GP. The dual, opposing roles of estrogen in the prostate. Annals of the New York Academy of Sciences. 2012;1155:174–186.

16. Gerstenbluth RE, Seftel AD, MacLennan GT, et al. Distribution of chronic prostatitis in radical prostatectomy specimens. Journal of Urology. 2002; 168(6):2267–2270.

17. John H, Barghorn A, Funke G, et al. Noninflammatory chronic pelvic pain syndrome: An immunological study in blood, seminal plasma, and prostate tissue. European Urology. 2010;38(5):564–568.

18. Karazanashvili G, Managadze L. Prostate-specific antigen (PSA) value changes after antibiotic treatment of prostate inflammation. European Urology. 2001;39(4):483–488.

19. Kramer G, Mitteregger D, Marberger M. Is benign prostatic hyperplasia (BPH) an immune-inflammatory disease? European Urology. 2007;51(5): 1202–1216.

20. Lackner JE, Märk I, Märk R, et al. Bacterial flora in the prostate: Important for pathogenesis? The Prostate. 2006;66(4):430–438.

21. Lowe FC, Ku JC. Phytotherapy in the treatment of benign prostatic hyperplasia: A critical review. Urology. 2006;48(1):12–20.

22. Magistro G, Wagenlehner FME, Grabe M, et al. Contemporary management of chronic prostatitis/chronic pelvic pain syndrome. European Urology. 2016;69(2):286–297.

23. Miyake M, Lawton A, Goodison S, et al. Epigenetic silencing of specific DNA regions in non-muscle invasive and muscle-invasive human bladder cancer cells. International Journal of Cancer. 2012;130 (9):2170–2180.

24. Nelson PS, Clegg N, Arnold H, et al. The program of androgen-responsive genes in neoplastic prostate epithelium. Proceedings of the National Academy of Sciences of the United States of America. 2016;99(18):11890–11895.

25. Nickel JC, Wagenlehner FME, Pontari M, et al. Continual improvement in the scientific methodology of chronic pelvic pain syndrome clinical trials. Current Urology Reports. 2013;14(4):334–339.

26. Parsons JK, Nelson CP, Gage WR, et al. GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue. The Prostate. 2004;49 (1):30–37.

27. Perlmutter MA, Lepor H. Androgen deprivation therapy in the treatment of advanced prostate cancer. Reviews in Urology. 2007;9(Suppl 1)–S8.

28. Pontari MA, Ruggieri MR. Mechanisms in prostatitis/chronic pelvic pain syndrome. Journal of Urology. 2004;172(3):839–845.

29. Rees J, Abrahams M, Doble A, Cooper A. Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: A consensus guideline. BJU International. 2015;116(4):509–525.

30. Sfanos KS, De Marzo AM. Prostate cancer and inflammation: The evidence. Histopathology. 2012;60(1):199–215.

31. Shahed AR, Shoskes DA. Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: Correlation with Gram-positive bacterial growth and treatment response. Journal of Andrology. 2001;22(4):532–537.

32. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial–mesenchymal transitions in development and disease. Cell. 2009;139(5):871–890.

33. Vikram R, Sandler CM, Ng CS. Follow-up of benign prostatic hyperplasia: Role of imaging. American Journal of Roentgenology. 2012;189(1)–W6.

34. Xue Y, Smedts F, Debruyne FM, et al. Identification of intermediate cell types by keratin expression in the developing human prostate. The Prostate. 2014;34(4):292–301.